[1]
|
Uttley, L., Indave, B.I., Hyde, C., et al. (2020) Invited Commentary—WHO Classification of Tumors: How Should Tu-mours Be Classified? Expert Consensus, Systematic Reviews or Both. International Journal of Cancer, 146, 3516- 3521. https://doi.org/10.1002/ijc.32975
|
[2]
|
Villanueva, A. (2019) Hepatocellular Carcinoma. The New England Journal of Medicine, 380, 1450-1462.
https://doi.org/10.1056/NEJMra1713263
|
[3]
|
Zhong, J., et al. (2014) Hepatic Resection Associated with Good Survival for Selected Patients with Intermediate and Advanced-Stage Hepatocellular Carcinoma. Annals of Surgery, 260, 329-340.
https://doi.org/10.1097/SLA.0000000000000236
|
[4]
|
Emmanuel, M., Martin, H., Michael, S., et al. (2016) Guide-lines for Perioperative Care for Liver Surgery: Enhanced Recovery after Surgery (ERAS) Society Recommendations. World Journal of Surgery, 40, 2425-2440.
https://doi.org/10.1007/s00268-016-3700-1
|
[5]
|
Schreckenbach, T., Liese, J., Bechstein, W.O. and Moench, C. (2012) Posthepatectomy Liver Failure. Digestive Surgery, 29, 79-85. https://doi.org/10.1159/000335741
|
[6]
|
Rahbari, N.N., James, G.O., Robert, P., et al. (2011) Post-Hepatectomy Haemorrhage: A Definition and Grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford), 13, 528-535.
https://doi.org/10.1111/j.1477-2574.2011.00319.x
|
[7]
|
Eguchi, H., Umeshita, K., Sakon, M., et al. (2000) Pres-ence of Active Hepatitis Associated with Liver Cirrhosisis a Risk Factor for Mortality Caused by Posthepatectomy Liver Failure. Digestive Diseases and Sciences, 45, 1383-1388.
https://doi.org/10.1023/A:1005564205755
|
[8]
|
Yoo, H.Y., Edwin, D. and Thuluvath, P.J. (2003) Relationship of the Model for End-Stage Liver Disease (MELD) Scale to Hepatic Encephalopathy, as Defined by Electroencephalography and Neuropsychometric Testing, and Ascites. The American Journal of Gastroenterology, 98, 1395-1399. https://doi.org/10.1111/j.1572-0241.2003.07466.x
|
[9]
|
Balzan, S., Belghiti, J., Farges, O., et al. (2005) The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death after Hepatectomy. Annals of Surgery, 242, 824-828.
https://doi.org/10.1097/01.sla.0000189131.90876.9e
|
[10]
|
Rahbari, N.N., Garden, O.J., Padbury, R., et al. (2011) Posthepatectomy Liver Failure: A Definition and Grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 149, 713-724.
https://doi.org/10.1016/j.surg.2010.10.001
|
[11]
|
Catherine, P., Sylvie, J., Didier, D., et al. (2009) Prospective Vali-dation of the “Fifty-Fifty” Criteria as an Early and Accurate Predictor of Death after Liver Resection in Intensive Care Unit Patients. Annals of Surgery, 249, 124-128.
https://doi.org/10.1097/SLA.0b013e31819279cd
|
[12]
|
van den Broek, M.A.J., Olde, D., Dejong, C.H.C., et al. (2008) Liver Failure after Partial Hepatic Resection: Definition, Pathophysiology, Risk Factors and Treatment. Liver In-ternational, 28, 767-780.
https://doi.org/10.1111/j.1478-3231.2008.01777.x
|
[13]
|
Yuen, M.F., et al. (2009) Hepatocellular Carcinoma in the Asia Pacific Region. Journal of Gastroenterology and Hepatology, 24, 346-353. https://doi.org/10.1111/j.1440-1746.2009.05784.x
|
[14]
|
Jordi, B. and Morris, S. (2011) Management of Hepatocel-lular Carcinoma: An Update. Hepatology (Baltimore, Md), 9, 452-463.
|
[15]
|
Alessandro, C., Giorgio, E., Matteo, C., et al. (2006) Recovery from Liver Failure after Hepatectomy for Hepatocellular Carcinoma in Cirrhosis: Meaning of the Model for End-Stage Liver Disease. Journal of the American College of Surgeons, 203, 670-676. https://doi.org/10.1016/j.jamcollsurg.2006.06.018
|
[16]
|
Wang, Y.Y., et al. (2016) Albumin-Bilirubin versus Child-Pugh Score as a Predictor of Outcome after Liver Resection for Hepatocellular Carcinoma. British Journal of Sur-gery, 103, 725-734. https://doi.org/10.1002/bjs.10095
|
[17]
|
Zou, H., et al. (2018) A Comparative Study of Albu-min-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients. Digestive Diseases (Basel, Switzerland), 36, 236-243. https://doi.org/10.1159/000486590
|
[18]
|
Tsuyoshi, I., Takahiro, U., Shigekazu, T., et al. (2009) A Simple, Noninvasively Determined Index Predicting Hepatic Failure Following Liver Resection for Hepatocellular Car-cinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 16, 42-48. https://doi.org/10.1007/s00534-008-0003-4
|
[19]
|
Xu, L., et al. (2015) Prognostic Nomogram for Patients with Un-resectable Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. Journal of Hepatology, 63, 122-130. https://doi.org/10.1016/j.jhep.2015.02.034
|
[20]
|
Ganne-Carrié, N., Layese, R., Bourcier, V., et al. (2016) Nomo-gram for Individualized Prediction of Hepatocellular Carcinoma Occurrence in Hepatitis C Virus Cirrhosis (ANRS CO12 CirVir). Hepatology, 64, 1136-1147.
https://doi.org/10.1002/hep.28702
|
[21]
|
François, D. and Dominique, V. (2005) Assessment of the Prognosis of Cirrhosis: Child-Pugh versus MELD. Journal of Hepatology, 42, S100-S107. https://doi.org/10.1016/j.jhep.2004.11.015
|
[22]
|
Russell, W., Erick, E., Richard, F., et al. (2003) Model for End-Stage Liver Disease (MELD) and Allocation of Donor Livers. Gastroenterology, 124, 91-96. https://doi.org/10.1053/gast.2003.50016
|
[23]
|
Teh-Ia H, Han-Chieh L, Cheng-Yuan H, et al. (2007) The Model for End-Stage Liver Disease-Based Cancer Staging Systems Are Better Prognostic Models for Hepatocellular Carcinoma: A Prospective Sequential Survey. The American Journal of Gastroenterology, 102, 1920-1930. https://doi.org/10.1111/j.1572-0241.2007.01370.x
|
[24]
|
Johnson, P.J., Sarah, B., Chiaki, K., et al. (2015) Assess-ment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558.
https://doi.org/10.1200/JCO.2014.57.9151
|
[25]
|
Lau, W., Leung, K., Leung, T.W., et al. (1997) A Logical Ap-proach to Hepatocellular Carcinoma Presenting with Jaundice. Annals of Surgery, 225, 281-285. https://doi.org/10.1097/00000658-199703000-00007
|
[26]
|
Liu, P.H., et al. (2017) ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era. Journal of Gastroenterology and Hepatology, 32, 879-886. https://doi.org/10.1111/jgh.13608
|
[27]
|
Mai, R.Y., Ye, J.Z., Long, Z.R., et al. (2019) Preoperative Aspartate Minotransferase-to-Platelet-Ratio Index as a Predictor of Posthepatectomy Liver Failure for Re-sectable Hepatocellular Carcinoma. Cancer Management and Research, 11, 1401-1414. https://doi.org/10.2147/CMAR.S186114
|
[28]
|
Le Roy, B., Gregoire, E., Cosse, C., et al. (2018) Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population. World Journal of Surgery 42, 2570-2578.
https://doi.org/10.1007/s00268-018-4464-6
|
[29]
|
Wakabayashi, H., Yachida, S., Maeba, T. and Maeta, H. (2002) Evaluation of Liver Function for the Application of Preoperative Portal Vein Embolization on Major Hepatic Resection. Hepatogastroenterology, 49, 1048-1052.
|
[30]
|
Yokoyama, Y., Ebata, T., Igami, T., et al. (2016) The Predictive Value of Indocyaninegreen Clearance in Future Liver Remnant for Posthepatectomy Liver Failure Following Hepatectomy with Extrahepatic Bile Duct Resection. World Journal of Surgery 40, 1440-1447. https://doi.org/10.1007/s00268-016-3441-1
|
[31]
|
Torzilli, G., Makuuchi, M., Inoue, K., Takayama T, et al. (1999) No-Mortality Liver Resection for Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients: Is There a Way? A Prospective Analysis of Our Approach. The Archives of Surgery, 134, 984-992. https://doi.org/10.1001/archsurg.134.9.984
|
[32]
|
Maruyama, M., Yoshizako, T., Araki, H., et al. (2018) Future Liver Remnant Indocyanine Green Plasma Clearance Rate as a Predictor of Post-Hepatectomy Liver Failure after Portal Vein Embolization. CardioVascular and Interventional Radiology, 41, 1877-1884. https://doi.org/10.1007/s00270-018-2065-2
|
[33]
|
Hwang, S., Ha, T.Y., Song, G.W., et al. (2015) Quantified Risk Assessment for Major Hepatectomy via the Indocyanine Green Clearance Rate and Liver Volumetry Combined with Standard Liver Volume. Journal of Gastrointestinal Surgery 19, 1305-1314. https://doi.org/10.1007/s11605-015-2846-8
|
[34]
|
Yada, K., Morine, Y., Ishibashi, H., et al. (2018) Treatment Strategy for Successful Hepatic Resection of Icteric Liver. The Journal of Medical Investigation, 65, 37-42. https://doi.org/10.2152/jmi.65.37
|
[35]
|
Wagener, G. (2013) Assessment of Hepatic Function, Operative Candidacy, and Medical Management after Liver Resection in the Patient with Underlying Liver Disease. Seminars in Liver Disease, 33, 204-212.
https://doi.org/10.1055/s-0033-1351777
|
[36]
|
Rassam, F., Olthof, P.B., Bennink, R.J. and van Gulik, T.M. (2017) Current Modalities for the Assessment of Future Remnant Liver Function. Visceral Medicine 33, 442-448. https://doi.org/10.1159/000480385
|
[37]
|
Mizutani, Y., Hirai, T., Nagamachi, S., et al. (2018) Prediction of Posthepatectomy Liver Failure Proposed by the International Study Group of Liver Surgery: Residual Liver Function Es-timation with 99mTc-Galactosyl Human Serum Albumin Scintigraphy. Clinical Nuclear Medicine, 43, 77-81. https://doi.org/10.1097/RLU.0000000000001913
|
[38]
|
Yoshida, M., Shiraishi, S., Sakamoto, F., et al. (2014) As-sessment of Hepatic Functional Regeneration after Hepatectomy Using (99m) Tc-GSA SPECT/CT Fused Imaging. An-nals of Nuclear Medicine, 28, 780-788.
https://doi.org/10.1007/s12149-014-0872-3
|
[39]
|
Nakamura, I., Iimuro, Y., Hai, S., et al. (2018) Impaired Value of 99m Tc-GSA Scintigraphy as an Independent Risk Factor for Posthepatectomy Liver Failure in Patients with Hepatocel-lular Carcinoma. European Surgical Research, 59, 12-22. https://doi.org/10.1159/000484044
|
[40]
|
Mizuguchi, T., Kawamoto, M., Meguro, M., Hui, T.T. and Hirata, K. (2014) Preoperative Liver Function Assessments to Estimate the Prognosis and Safety of Liver Resections. Surgery Today, 44, 1-10.
https://doi.org/10.1007/s00595-013-0534-4
|
[41]
|
Cieslak, K.P., Runge, J.H., Heger, M., et al. (2014) New Perspec-tives in the Assessment of Future Remnant Liver. Digestive Surgery, 31, 255-268. https://doi.org/10.1159/000364836
|
[42]
|
de Graaf, W., van Lienden, K.P., Dinant, S., et al. (2010) Assessment of Future Remnant Liver Function Using Hepatobiliary Scintigraphy in Patients Undergoing Major Liver Resection. Journal of Gastrointestinal Surgery, 14, 369-378.
https://doi.org/10.1007/s11605-009-1085-2
|
[43]
|
Rassam, F., Olthof, P.B., Richardson, H., et al. (2019) Practical Guidelines for the Use of Technetium-99m Mebrofenin Hepatobiliary Scintigraphy in the Quantitative Assessment of Liver Function. Nuclear Medicine Communications, 40, 297-307. https://doi.org/10.1097/MNM.0000000000000973
|
[44]
|
Chapelle, T., Op de Beeck, B., Roeyen, G., et al. (2017) Measuring Future Liver Remnant Function Prior to Hepatectomy May Guide the Indication for Portal Vein Occlusion and Avoid Posthepatectomy Liver Failure: A Prospective Interventional Study. HPB (Oxford), 19, 108-117. https://doi.org/10.1016/j.hpb.2016.11.005
|
[45]
|
Truant, S., Baillet, C., Fulbert, M., et al. (2019) Asymmetric Kinet-ics of Volume and Function of the Remnant Liver after Major Hepatectomy as a Key for Postoperative Outcome—A Case-Matched Study. HPB (Oxford), 22, 855-863.
https://doi.org/10.1016/j.hpb.2019.10.008
|
[46]
|
Han, H., Hu, H., Wang, W.P., et al. (2017) Liver Failure after Hepatectomy: A Risk Assessment Using the Pre-Hepa- tectomy Shear Wave Elastography Technique. European Journal of Radiology, 86, 234-240.
|
[47]
|
Lei, J.-W., Ji, X.-Y., Hong, J.-F., et al. (2017) Prediction of Posthepatectomy Liver Failure Using Transient Elastography in Patients with Hepatitis B Related Hepatocellular Carcinoma. BMC Gastroenter-ology, 17, 171.
https://doi.org/10.1186/s12876-017-0732-4
|
[48]
|
Squires III, M.H., Dann, G.C., Lad, N.L., et al. (2014) Hypo-phosphataemia after Major Hepatectomy and the Risk of Post-Operative Hepatic Insufficiency and Mortality: An Analy-sis of 719 Patients. HPB (Oxford), 16, 884-891.
https://doi.org/10.1111/hpb.12276
|
[49]
|
Salem, R.R. and Tray, K. (2005) Hepatic Resection-Related Hypophos-phatemia Is of Renal Origin as Manifested by Isolated Hyperphosphaturia. Annals of Surgery, 241, 343-348. https://doi.org/10.1097/01.sla.0000152093.43468.c0
|
[50]
|
Nafidi, O., Lepage, R., Lapointe, R.W. and D’Amour, P. (2007) Hepatic Resection-Related Hypophosphatemia Is of Renal Origin as Manifested by Isolated Hyperphosphaturia. Annals of Surgery 245, 1000-1002.
https://doi.org/10.1097/SLA.0b013e31805d0882
|
[51]
|
Nomura, K., Tatsumi, S., Miyagawa, A., et al. (2014) Hepa-tectomy-Related Hypophosphatemia: A Novel Phosphaturic Factor in the Liver-Kidney Axis. Journal of the American Society of Nephrology, 25, 761-772.
https://doi.org/10.1681/ASN.2013060569
|
[52]
|
Takahashi, K., Murata, S. and Ohkohchi, N. (2013) Novel Therapy for Liver Regeneration by Increasing the Number of Platelets. Surgery Today, 43, 1081-1087. https://doi.org/10.1007/s00595-012-0418-z
|
[53]
|
Maruyama, T., Murata, S., Takahashi, K., et al. (2013) Platelet Transfusion Improves Liver Function in Patients with Chronic Liver Disease and Cirrhosis. The Tohoku Journal of Ex-perimental Medicine, 229, 213-220.
https://doi.org/10.1620/tjem.229.213
|
[54]
|
梅理祥, 李增博, 谢艳会, 等. 肝切除术后第3天ICG-R15对肝细胞肝癌术后肝功能不全的预测价值[J]. 中国普通外科杂志, 2016, 25(8): 1180-1185. https://doi.org/10.3978/j.issn.1005-6947.2016.08.016
|